Saar Külliki, Saar Helgi, Hansen Mats, Langel Ülo, Pooga Margus
Institute of Molecular and Cell Biology, University of Tartu; Riia Street 23, 51010 Tartu, Estonia.
Department of Pathology, University of Tartu Hospital; Puusepa Street 8, 50411 Tartu, Estonia.
Pharmaceuticals (Basel). 2010 Mar 12;3(3):621-635. doi: 10.3390/ph3030621.
Interest in cell-penetrating peptides (CPPs) as delivery agents has fuelled a large number of studies conducted on cultured cells and in mice. However, only a few studies have been devoted to the behaviour of CPPs in human tissues. Therefore, we performed ex vivo tissue-dipping experiments where we studied the distribution of CPP-protein complexes in samples of freshly harvested human tissue material. We used the carcinoma or hyperplasia-containing specimens of the uterus and the cervix, obtained as surgical waste from nine hysterectomies. Our aim was to evaluate the tissue of preference (epithelial versus muscular/connective tissue, carcinoma versus adjacent histologically normal tissue) for two well-studied CPPs, the transportan and the TAT-peptide. We complexed biotinylated CPPs with avidin--galactosidase (ABG), which enabled us to apply whole-mount X-gal staining as a robust detection method. Our results demonstrate that both peptides enhanced the tissue distribution of ABG. The enhancing effect of the tested CPPs was more obvious in the normal tissue and in some specimens we detected a striking selectivity of CPP-ABG complexes for the normal tissue. This unexpected finding encourages the evaluation of CPPs as local delivery agents in non-malignant situations, for example in the intrauterine gene therapy of benign gynaecological diseases.
对细胞穿透肽(CPPs)作为递送剂的兴趣推动了大量在培养细胞和小鼠中进行的研究。然而,仅有少数研究关注CPPs在人体组织中的行为。因此,我们开展了体外组织浸渍实验,研究了CPP - 蛋白质复合物在新鲜采集的人体组织材料样本中的分布情况。我们使用了从9例子宫切除术中作为手术废弃物获取的子宫和宫颈含癌或增生的标本。我们的目的是评估两种经过充分研究的CPPs(转运蛋白和TAT肽)对组织的偏好性(上皮组织与肌肉/结缔组织、癌组织与组织学上相邻的正常组织)。我们将生物素化的CPPs与抗生物素蛋白 - β - 半乳糖苷酶(ABG)复合,这使我们能够应用全组织X - 半乳糖染色作为一种可靠的检测方法。我们的结果表明,两种肽均增强了ABG在组织中的分布。在正常组织中,所测试的CPPs的增强作用更为明显,并且在一些标本中我们检测到CPP - ABG复合物对正常组织具有显著的选择性。这一意外发现促使人们评估CPPs作为非恶性情况下的局部递送剂,例如用于良性妇科疾病的宫内基因治疗。